期刊文献+

糖化白蛋白临床研究进展 被引量:7

The clinical advances of glycated albumin
原文传递
导出
摘要 血糖监测是糖尿病管理中的重要环节,糖化血红蛋白(HbA1e)作为一个血糖长期监测的指标,在一些情况下(造血系统疾病、餐后高血糖、血糖控制快速恶化等)不能准确反映患者血糖快速变化。糖化白蛋白(GA)可准确反映短期血糖变化,在早期发现糖尿病,评价降糖药物疗效,预测糖尿病血管并发症的风险以及监测造血系统疾病患者的血糖控制方面可作为一个有效的指标。中华检验医学杂志,2014.37:887—889) Glycemic control is essential to diabetes management. HbA1e, is often used as the gold standard of glycemic monitoring indicators. However, HbA1e, may not accurately reflect glycemic control in various conditions such as hematologic disorders, postprandial hyperglycemia, glycemia deteriorate. GA can reflect the short-term glycemic change, screen for diabetes, evaluate treatment effect and predict the risk of diabetic vascular complications. GA could be a more useful glycemic control indicator. ( Chin J Lab Med, 2014,37:887-889)
作者 李海霞
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第12期887-889,共3页 Chinese Journal of Laboratory Medicine
关键词 血清白蛋白 血红蛋白A 糖基化 Serum albumin Hemoglobin A, glycosylated
  • 相关文献

参考文献2

二级参考文献25

  • 1The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986. 被引量:1
  • 2UK Prospective Diabetes Study Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853. 被引量:1
  • 3Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin Al c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420. 被引量:1
  • 4Tsujimoto Y, Ishimura E, Tahara H, Kakiya R, Koyama H, Emoto M, et al. Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes. Ther Apher Dial 2009; 13: 358-365. 被引量:1
  • 5Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol1998 9: SI6-S23. 被引量:1
  • 6US Renal Data System: USRDS 2009 annual data report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2009, 1st Edition: 489. 被引量:1
  • 7Ichikawa H, Nagake Y, Takahashi M, Nakazono H, Kawabata K, Shikata K, et al. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? Nippon Jinzo Gakkai Shi 1996; 38: 305-308. 被引量:1
  • 8Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, et al. Influence of erythropoietin treatment on hemoglobin Alc levels in patients with chronic renal failure on hemodialysis. Intern Med 1998; 37: 826-830. 被引量:1
  • 9Joy MS, Cefalu WT, Hogan SL, Nachman PH. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 2002; 39: 297-307. 被引量:1
  • 10Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979; 76: 4258- 4261. 被引量:1

共引文献8

同被引文献39

引证文献7

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部